Processa Pharmaceuticals, Inc. Contracts & Agreements

70 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Placement Agency Agreement
Agency Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2025
Warrant issued to Spartan Capital, Inc
Processa Pharmaceuticals, Inc.
2024
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Processa Pharmaceuticals, Inc.
2024
Form of Common Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2024
Form of Placement Agent Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2024
Form of Securities Purchase Agreement, dated January 26, 2024, by and between Processa Pharmaceuticals, Inc. and each of the Purchasers (as defined therein)
Purchase Agreements
Processa Pharmaceuticals, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2024
Form of Common Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2024
Form of Placement Agent Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2024
Form of Securities Purchase Agreement
Purchase Agreements
Processa Pharmaceuticals, Inc.
2024
Employment Agreement dated August 8, 2023 by and between George Ng and Processa Pharmaceuticals, Inc
Employment Agreements
Processa Pharmaceuticals, Inc.
2023
First Amendment to Consulting Agreement with Spartan Capital Securities, LLC
Consulting Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2023
Form of Securities Purchase Agreement, dated February 9, 2023, by and between Processa Pharmaceuticals, Inc. and each of the Investors (as defined therein)
Purchase Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
First Amendment to Lease Agreement for Processa Pharmaceuticals, Inc
Lease Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2022
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2022
Purchase Agreement, dated March 23, 2022, between Processa Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
Purchase Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Registration Rights Agreement, dated March 23, 2022, by and between Processa Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
IL
2022
Equity Distribution Agreement, dated August 20, 2021, by and among Processa Pharmaceuticals, Inc. and Oppenheimer & Co. Inc
Equity Distribution Agreements
Processa Pharmaceuticals, Inc.
2021
License Agreement dated June 16, 2021
License Agreements
Processa Pharmaceuticals, Inc.
2021
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Processa Pharmaceuticals, Inc.
2021
Addendum No. 1 to the Aposense Ltd. License Agreement
License Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2021
Securities Purchase Agreement dated February 16, 2021
Purchase Agreements
Processa Pharmaceuticals, Inc.
2021
Registration Agreement dated February 16, 2021
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2021
Form of Placement Agent Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2021
Employment Agreement, dated October 6, 2020, between Processa Pharmaceuticals and R. Michael Floyd
Employment Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
MD
2020
Underwriting Agreement, dated as of October 1, 2020, by and among the Company, Craig-Hallum Capital Group LLC and Benchmark Company, LLC, as representatives of several Underwriters
Underwriting Agreements
Processa Pharmaceuticals, Inc.
2020
Form of Underwriting Agreement
Underwriting Agreements
Processa Pharmaceuticals, Inc.
2020
Asset Purchase Agreement. Dated October 2, 2017, among the Company, Promet Therapeutics LLC and Processa Therapeutics LLC
Purchase Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Specimen of Common Stock Certificate
Stock Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
Warrant issued to PoC Capital, LLC
Warrant Agreements
Processa Pharmaceuticals, Inc.
2020
Warrants issued to Boustead Securities
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
Form of Subscription Agreement for Senior Convertible Notes
Note Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
Form of Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2020
Amended and Restated 2011 Equity Incentive Plan
Bonus & Incentive Agreements
Processa Pharmaceuticals, Inc.
2020
License Option Agreement with CoNCERT
License Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
Amendment to License Agreement and Securities Purchase Agreement with CoNCERT Pharmaceuticals
Purchase Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
Employment Agreement dated September 5, 2018, between Processa and James Stanker
Employment Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
MD
2020
Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan
Bonus & Incentive Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
MD
2020
Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and DKBK Enterprises, LLC
Credit Agreements
Processa Pharmaceuticals, Inc.
2020
Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and CorLyst, LLC
Credit Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
License Agreement with Akashi Therapeutics, Inc. dated August 29, 2019
License Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
License Agreement with Aposense, Ltd. dated May 24, 2020
License Agreements
Processa Pharmaceuticals, Inc.
2020
License Agreement with Yuhan Corporation
License Agreements
Processa Pharmaceuticals, Inc.
2020
Share Issuance Agreement pursuant to License Agreement with Yuhan Corporation
Share Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
NY
2020
License Agreement with Elion Oncology, Inc
License Agreements
Processa Pharmaceuticals, Inc.
2020
License Agreement by and between Processa Pharmaceuticals and Elion Oncology dated August 23, 2020
License Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
MD
2020
License Agreement by and between Processa Pharmaceuticals, Inc. and Yuhan Corporation, dated August 19, 2020
License Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
NY
2020
Share Issuance Agreement by and between Processa Pharmaceuticals, Inc. and Yuhan Corporation, dated August 19, 2020
Share Agreements
Processa Pharmaceuticals, Inc.
2020
Promissory Note, dated May 1, 2020, with Processa Pharmaceuticals, Inc. and Bank of America, N.A., received by the company under the Small Business Administration Paycheck...
Note Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2020
Form of 8% Senior Convertible Notes
Note Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2019
Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and DKBK Enterprises, LLC
Credit Agreements
Processa Pharmaceuticals, Inc.
2019
Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and CorLyst, LLC
Credit Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2019
Amendment to the Agreement between PoC Capital and Processa Pharmaceuticals, Inc. dated September 30, 2019
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2019
Pledge Agreement dated May 25, 2018, by and between Processa Pharmaceuticals, Inc. and PoC Capital, LLC
Pledge Agreements
Processa Pharmaceuticals, Inc.
2018
Employment Agreement, dated September 5, 2018, between Processa Pharmaceuticals and James Stanker
Employment Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
MD
2018
Boustead Engagement Letter
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2018
Form of Purchase Agreement
Purchase Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2018
Form of Warrant
Warrant Agreements
Processa Pharmaceuticals, Inc.
2018
License Option Agreement with CoNCERT
License Agreements
Processa Pharmaceuticals, Inc.
2018
Amendment to License Agreement and Securities Purchase Agreement with CoNCERT Pharmaceuticals
Purchase Agreements
Processa Pharmaceuticals, Inc.
2018
Convertible Note
Note Agreements
Processa Pharmaceuticals, Inc.
2018
Lock-Up Period
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2017
Lock-Up Period
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2017
ACQUISITION AGREEMENT By and Among HEATWURX, INC., a Delaware corporation PROCESSA THERAPEUTICS, LLC a Delaware limited liability company and PROMET THERAPEUTICS, LLC a Delaware...
Limited Liability Company Agreements
Processa Pharmaceuticals, Inc.
2017
PROMISSORY NOTE EXTENSION AGREEMENT ADDENDUM TO NOTES UNDER LOAN AGREEMENT: SENIOR SECURED LOAN AGREEMENT 2.16.15 Extended to February 15, 2016
Loan Agreements
Processa Pharmaceuticals, Inc.
2015
CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES D 8% CONVERTIBLE PREFERRED STOCK OF HEATWURX, INC. (As amended on November 20, 2013) Pursuant to Section 151 of the...
Stock Agreements
Processa Pharmaceuticals, Inc.
2014
HEATWURX, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Processa Pharmaceuticals, Inc.
2014
SENIOR LOAN AGREEMENT
Loan Agreements
Processa Pharmaceuticals, Inc.
2013
SUBORDINATION AGREEMENT
Subordination Agreement
Processa Pharmaceuticals, Inc.
2013
SETTLEMENT AND MUTUAL RELEASE AGREEMENT
Settlement Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
2013